Clinical trial registry record

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Registry ID
NCT03178149
Last registry update
September 3, 2026
Status
Recruiting
Phase
PHASE1
Sponsor
Astellas Institute for Regenerative Medicine
Enrollment
42
Countries
United States
Match confidence
68%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record matched · 68% confidence

Published automatically with 68% topic confidence after controlled-term evaluation.

  • Stem cells · 68%Legacy trial evaluated automatically against controlled title, summary, and longevity-context rules.

Source quality 100% · freshness 100%. These are automated routing signals, not medical or evidence-strength ratings.